Welcome 2011 Investor Meeting - NYC April 2011 Exhibit 99.1 |
2011 Investor Meeting Forward-looking statements www.amedisys.com NASDAQ: AMED We encourage everyone to visit the Investors Section of our website at www.amedisys.com, where we have posted additional important information such as press releases, profiles concerning our business and clinical operations and control processes, and SEC filings. We intend to use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the SEC disclosing the same information. 2 This presentation may include forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current expectations and assumptions about our business that are subject to a variety of risks and uncertainties that could cause actual results to differ materially from those described in this presentation. You should not rely on forward-looking statements as a prediction of future events. Additional information regarding factors that could cause actual results to differ materially from those discussed in any forward-looking statements are described in reports and registration statements we file with the SEC, including our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, copies of which are available on the Amedisys internet website department at (800) 467-2662. We disclaim any obligation to update any forward-looking statements or any changes in events, conditions or circumstances upon which any forward-looking statement may be based except as required by law. http://www.amedisys.com or by contacting the Amedisys Investor Relations |
2011 Investor Meeting Meeting flow Now – 11:45 am Morning Presentations 11:45 – 12:45 Lunch / break 12:45 - 3 pm Afternoon presentations 3 |
2011 Investor Meeting State of the Company William F. Borne, Chairman and CEO 4 |
2011 Investor Meeting Goals Showcase the way we’ve optimized our operations Clearly define our growth strategy Reiterate our commitment to compliance 5 |
2011 Investor Meeting 6 Today’s presenters William F. Borne, Chairman & CEO Michael Snow, Chief Operating Officer Michael Fleming, MD, FAAFP Chief Medical Officer Jeffrey Jeter, JD Chief Compliance Officer Dave Monic, VP Clinical Informatics Patrick Thompson, EVP Administration Chief Information Officer Leigh Ann Witcher Templeton, VP Office Informatics Kendra Case, VP Clinical Development |
2011 Investor Meeting Company Overview “Leading Home Health & Hospice” 7 |
2011 Investor Meeting Leading Home Health & Hospice Traditional Measures – Home Health 8 Amedisys Gentiva LHCG Almost Family Home Health Revenue (2010 - $M) $1,493 $1,096 $559 $295 States Serving 45 39 19 11 Total Locations 489 350+ 251 87 |
2011 Investor Meeting Leading Home Health & Hospice Traditional Measures - Hospice 9 Amedisys Gentiva LHCG Vitas Hospice Revenue (2010 - $M) $141 $800 ~$40 $925 States Serving 20 30 9 15 Total Locations 69 170 33 102 |
2011 Investor Meeting Differentiating industry leadership metrics Management • Strong Home Health and Hospice leadership Commitment to quality • National roll-out of Care Transitions • Numerous quality pilot programs and “R&D” • Focus on reducing acute care hospitalizations Focus on the care continuum • Clinical innovation in advanced chronic care management • Collaborative technology • Engaging regulators and policy-makers in Washington Patti Waller, EVP Home Health Care Jim Robinson, EVP Hospice Care |
2011 Investor Meeting 11 2011 Overview • After tremendous growth, 2010 was a year to reset – Decentralize operations – Leadership investments – In-depth portfolio review – Re-focus on costs – Next generation IT investments • 2011 Headwinds – ~ 5% cut to home health – F2F/Therapy Assessments – Slower growth $- $500 $1,000 $1,500 $2,000 2007 2008 2009 2010 $ Millions Amedisys Historical Financials Revenue EBITDA |
2011 Investor Meeting Lifestyle / Chronic Disease: Obesity in America Percent of Obese U.S. Adults (BMI > 30) 12 |
13 > $2.5 trillion / year > $800 billion – $1.2 trillion in waste > $6.2 trillion in cuts / 10 years We are facing a crisis. 2011 Investor Meeting |
2011 Investor Meeting A New Path: National Reform Efforts Patient-Centered Medical Home Value-Based Purchasing Independence at Home Accountable Care Organizations Bundled Payments Pay-for-Performance 14 |
Migration from episode management to continuum management Lower-cost setting with industry- leading technology, processes and talent that make us efficient These are our patients Why is Amedisys Part of the Answer? AGING POPULATION WASTE INEFFICIENCY LIFESTYLE / CHRONIC DISEASE 15 2011 Investor Meeting |
Evolution of traditional home health 16 |
Current State: Post-Acute Care Traditional Home Care Episode Acute Episode (HF) Home Health Treatment Home Health Treatment Home Health Treatment Acute Episode (HF) Patient discharged from hospital to home care Patient continuing to improve, home care is recertified CHF stable, patient discharged from home care New CHF exacerbation & hospital admission 0 3 60 120 200 205 Timeline Episode Begins Again… 17 Traditional Home Care |
Future State Continuum of Care Physician Visit Continuous Care Management Home Care Assessment & Visits NP Home Visit Office visit triggers physician to order management and coordination at home Possible exacerbation reported via telehealth/monitoring Patient assessment; clinical track assigned; medication reconciliation; patient education; telehealth/monitoring Immediate clinician visit; physician notified; plan of care assessed and modified Increased Therapy & Nursing Visits Chronic disease management -- possibly under capitation or other risk-based model 18 Timeline |
2011 Investor Meeting The Amedisys strategic roadmap Patients / health care system value Today: Focus on the basics and prepare for change Tomorrow: Differentiated provider of care management •Build Infrastructure •Organic Growth •Grow Hospice •Advance Care Capabilities •Policy Dialogue 19 •Care management capability •Revenue diversity - Hospitals - Health systems - Managed care •Capitation / Risk Sharing •Collaborative IT •Policy engagement |
2011 Investor Meeting Operations update Mike Snow, Chief Operating Officer 20 |
2011 Investor Meeting Rapid growth In the past two and a half years (2007– 2010), Amedisys has grown from: 9,000 employees to 17,000 354 sites to more than 550 today $700M in revenues to $1.65B 1 today 21 1 Annualized revenue guidance provided as of the date of our Form 8-K filed with the Securities and Exchange Commission on August 9, 2010. |
2011 Investor Meeting Agency Locations 22 489 - Home Health locations 69 - Hospice locations Beacon Hospice Care Centers Amedisys Hospice Care Centers Amedisys Home Health Care Centers |
2011 Investor Meeting Balancing centralized resources and decentralized ownership of markets 23 Engaged talent. Tools for success. Grow local markets. 2011 Investor Meeting |
Our Long-term Operating Tenets 24 2011 Investor Meeting |
2011 Investor Meeting Focus on Clinical Outcomes 25 Amedisys vs. Footprint – Outcomes December 2009 • Exceeded or met 11 out of 12 outcomes vs. footprint 1 Lower % is better Source: Medicare |
2011 Investor Meeting Quality Care Initiatives 26 |
2011 Investor Meeting Focus on Clinical Outcomes 27 • Internal ACH rate – Trailing 12 Months Note: Data only includes agencies in the 2009 Baseline dataset . |
2011 Investor Meeting The Numbers Current Medicare Readmission Rates Rehospitalizations among Patients in the Medicare Fee-for-Service Program. Stephen F. Jencks, M.D., M.P.H., Mark V. Williams, M.D., and Eric A. Coleman, M.D., M.P.H. N Engl J Med 2009; 360:1418-1428April 2, 2009 28 |
2011 Investor Meeting Growth - Organic 29 Tactical growth initiatives • Care center action plans • Heightened focus on low performers • Leading indicators • Measure effectiveness 1 Same store episodic-based admission growth is the percent increase in our same store episodic-based admissions for the period as a percent of the same store episodic-based admissions of the prior period. • New regional leadership • Training & development • CRM tool / market intel • Incentive alignment 3% 6% -2% 15% 12% 18% -5% 0% 5% 10% 15% 20% 2009 2010 1Q 2011 Same Store Episodic-Based Admission Growth 1 Home Health Hospice |
2011 Investor Meeting Growth - Organic 30 Strategic growth initiatives |
2011 Investor Meeting Growth - External 31 Industry Consolidation – 10,500 home health provider numbers – 3,400 hospice provider numbers – 12-15% public company market share Focus – CON markets – Geographic expansion – Market penetration – Hospital JV’s Continuum of care Traditional Investments Complementary Investments – Care management capabilities – Revenue diversification – Disease Management |
2011 Investor Meeting Beacon Acquisition • Premier hospice in Northeast – 23 locations – $80 million in revenue – Quality provider – Strong leadership and operations 32 Beacon Hospice Care Centers Amedisys Hospice Care Centers Amedisys Home Health Care Centers |
2011 Investor Meeting Efficiency – Systems Infrastructure 33 |
Efficiency – labor 34 • Cost per visit improvements - Pay per visit focus - Reduction in overtime - Weekly visit metrics • Field Overhead - Staffing ratios - Streamline leadership - Closures/Mergers • Hospice - Reduced pharma costs - Leverage overhead thru growth 1 *Adjusted for holiday pay and inclement weather $71.00 $71.50 $72.00 $72.50 $73.00 $73.50 $74.00 $74.50 $78.00 $78.50 $79.00 $79.50 $80.00 $80.50 $81.00 $81.50 $82.00 $82.50 $83.00 1Q 10 2Q 10 3Q 10 4Q 10 1Q 11 Home Health Cost per Visit* Hospice Cost per Day 2011 Investor Meeting |
2011 Investor Meeting The Paradigm Shift 35 Green LA, Fryer GE Jr, Yawn BP, Lanier D, Dovey SM. The ecology of medical care revisited. N Engl J Med. 2001 Jun 28;344(26):2021-5. |
2011 Investor Meeting We’re Ready 36 |
2011 Investor Meeting Quality = growth Michael Fleming, MD, FAAFP - Chief Medical Officer Kendra Case, VP Clinical Development 37 |
2011 Investor Meeting Amedisys Strategic Advisory Board 38 Dr. Peter Boling Virginia Commonwealth University Dr. Allen Dobson Carolinas Healthcare System/ Cabarrus Family Medicine Dr. Steven Landers Cleveland Clinic Dr. Bruce Leff Johns Hopkins University School of Medicine Dr. Mike Magee Positive Medicine, Inc. Dr. Frank Opelka Louisiana State University Health Sciences Center |
2011 Investor Meeting Physician Engagement: Power of the Pen 39 |
2011 Investor Meeting Defining Quality in Healthcare Institute of Medicine’s Characteristics for Quality Care 40 |
2011 Investor Meeting “It is not the strongest of the species that survives, nor the most intelligent, but the one most responsive to change.” - Charles Darwin 41 |
2011 Investor Meeting We’re Evolving 42 |
2011 Investor Meeting Amedisys clinical resources are second to none. 43 Provides guidance, education, and clinical infrastructure to the care centers to comply with federal as well as state regulatory bodies |
2011 Investor Meeting Amedisys clinical resources are second to none. 44 Provides support to care centers to ensure they are in compliance with license renewals, personnel changes, CON reporting requirements etc |
2011 Investor Meeting • Create and Manage Condition-Specific Programs • Create and Manage Chronic Disease Programs • Corporate clinical support for other general programs • Research & Development Amedisys clinical resources are second to none. 45 |
2011 Investor Meeting Evidence-based Programs Partners in Wound Care® Wound Care Rehab Therapy @ Home Rehabilitation Empowered for Life Psychiatric Surgical Recovery @ Home Post Surgery COPD @ Home Chronic Obstructive Pulmonary Disease Diabetes @ Home Diabetes Heart @ Home Cardiac Disease Stroke Recovery @ Home Stroke Chronic Kidney Disease @ Home Kidney Disease Pain Management @ Home Chronic Pain Balanced for Life Fall Prevention Enables our clinical staff to provide the highest level of care consistently nationwide while controlling costs through a demonstrated plan of care |
Care Transitions Program 47 • Coordinate transition to home care • Initiate patient health history and patient health • Promote follow-up physician visit • Initiate medication • Patient education & coaching • Medication management • Patient self-management of chronic diseases (Bridge to Healthy Living) • Focus on Physician follow- up and engagement record reconciliation 2011 Investor Meeting |
www.cardiocom.com Telemonitoring: Helping Amedisys effectively and efficiently monitor complex patients in their home Remote Patient Monitoring 48 |
2011 Investor Meeting Advanced Chronic Care Management 49 |
Spotlight On Palliative Care @ Home Terminal Phase of Illness Diagnosis World Health Organization (2002) 50 |
Home-based Palliative Care 51 |
Innovation of Health Care at Home 52 Care Transitions pilot for congestive heart failure population HCA Richmond Care Preferred Provider – CHF patients Palliative Care / End-of-Life Care 2011 Investor Meeting |
53 Questions & Answers Morning Session 2011 Investor Meeting |
2011 Investor Meeting Home health day-to-day operations overview • Provide investors better clarity on home health operations and billing • Describe our IT investment and the efficiencies it drives • Compliance wraps it up Agenda • IT systems that support daily operations • Overview of process from referral to final billing • Point-of-Care demonstration • Clinical management • Mercury Doc • Compliance 54 Afternoon Overview |
2011 Investor Meeting Best-in-class technology Patrick Thompson, EVP Administration and CIO 55 |
Quality – Point-of-care – Clinicians at patient’s home – Clinical Management oversight – Circle of Care tools for patients and care teams – Consistent & enhanced clinician training and delivery of @Home services Efficiency – Mobile workforce – Care Center efficiencies – Back-office automation – Collaboration & Communication – Agility & Speed of Business – Continuum Care solutions Growth – Market intelligence – Focused Targets – Enhance communication with referral sources – Scalability – Acquisition optimization The Amedisys IT mission: • Support the company’s core tenets • Provide the right info, at the right time, anywhere 2011 Investor Meeting |
57 Clinical & Office Informatics Amedisys Continuum Care Enterprise Information System Skill match scheduling with patient needs Multi-Care Center scheduling to optimize mobile workforce Productivity scheduling to optimize workforce 2011 Investor Meeting |
58 Clinical & Office Informatics Amedisys Continuum Care Enterprise Information System Patient care at bedside Evidence based rules Clinical tracks and modules 14,000 mobile clinicians Smart edits Re-Hospitalization alerts 2011 Investor Meeting |
59 Clinical & Office Informatics Amedisys Continuum Care Enterprise Information System 10,000,000 visits for 400,000 patients annually Clinical management dashboards Quality Care alerts Re-Hospitalization alerts 2011 Investor Meeting |
60 Clinical & Office Informatics Amedisys Continuum Care Enterprise Information System Greater than 99 percent Medicare collection rate Driving down DSO rate Automated billing 2011 Investor Meeting |
2011 Investor Meeting 61 Amedisys Continuum Care Enterprise Information System Reduce inventory on shelf Just in time delivery to patient home Order from care plan Clinical & Office Informatics |
2011 Investor Meeting 62 Millions of patients trends and care analysis Role based dashboards for all key care center roles Re-Hospitalization alerts Productivity alerts Enterprise Business & Client Systems Platform Clinical & Office Informatics Amedisys Continuum Care Enterprise Information System |
2011 Investor Meeting 63 Amedisys Continuum Care Enterprise Information System Referral capture Integration with CIS Care Transition Solution Productivity alerts Clinical & Office Informatics Enterprise Business & Client Systems Platform |
2011 Investor Meeting 64 Amedisys Continuum Care Enterprise Information System Circle of Care Physician portal Patient/family portal Care Team portal Enterprise Business & Client Systems Platform Clinical & Office Informatics |
2011 Investor Meeting 65 Amedisys Continuum Care Enterprise Information System Financials HR Payroll Supply Chain Clinical & Office Informatics Enterprise Business & Client Systems Platform |
2011 Investor Meeting 66 Amedisys Continuum Care Enterprise Information System Over 8,000 physicians 27% admissions Collaborative Care Medical reconciliation Re-Hospitalization alerts Clinical & Office Informatics Enterprise Business & Client Systems Platform |
2011 Investor Meeting 67 Clinical & Office Informatics Amedisys Continuum Care Enterprise Information System Enterprise Business & Client Systems Platform @ Home Hospice Hospitals |
2011 Investor Meeting Medicare Billing/ Reimbursement Overview Kendra Case, VP Clinical Development 68 |
2011 Investor Meeting Medicare Billing/Reimbursement Overview 69 PROCESS Referral sources • Hospitals • Physicians • Other facilities 1 Referral 2 Initial Visit 3 Plan of Care Developed 4 Locked OASIS 5 The RAP 6 7 Plan of Care Implemented Final Bill & Payment F2F initiated • Prior to discharge • Upon admission |
2011 Investor Meeting Medicare Billing/Reimbursement Overview 70 PROCESS 1.5 – 2 hour clinician assessment • OASIS • POC technology • Data checks 1 Referral 2 Initial Visit 3 Plan of Care Developed 4 Locked OASIS 5 The RAP 6 7 Plan of Care Implemented Final Bill & Payment |
2011 Investor Meeting Medicare Billing/Reimbursement Overview 71 PROCESS Development • Created by RN or PT • Clinical Tracks • Certification 1 Referral 2 Initial Visit 3 Plan of Care Developed 4 Locked OASIS 5 The RAP 6 7 Plan of Care Implemented Final Bill & Payment |
2011 Investor Meeting Medicare Billing/Reimbursement Overview 72 PROCESS 1 Referral 2 Initial Visit 3 Plan of Care Developed 4 Locked OASIS 5 The RAP 6 7 Plan of Care Implemented Final Bill & Payment |
2011 Investor Meeting Medicare Billing/Reimbursement Overview 73 PROCESS Coding accuracy • Manually Calculated Audits • FI Audits - ADRs or Probe Edits 1 Referral 2 Initial Visit 3 Plan of Care Developed 4 Locked OASIS 5 The RAP 6 7 Plan of Care Implemented Final Bill & Payment |
2011 Investor Meeting Medicare Billing/Reimbursement Overview 74 PROCESS • The RAP is sent to the FI • The FI sends the RAP through its own scrubber 1 Referral 2 Initial Visit 3 Plan of Care Developed 4 Locked OASIS 5 The RAP 6 7 Plan of Care Implemented Final Bill & Payment |
2011 Investor Meeting Medicare Billing/Reimbursement Overview 75 PROCESS • Plan of Care Implemented • Changes require MD order 1 Referral 2 Initial Visit 3 Plan of Care Developed 4 Locked OASIS 5 The RAP 6 7 Plan of Care Implemented Final Bill & Payment |
2011 Investor Meeting Medicare Billing/Reimbursement Overview 76 PROCESS • Final bill sent to FI • FI Scrubber 1 Referral 2 Initial Visit 3 Plan of Care Developed 4 Locked OASIS 5 The RAP 6 7 Final Bill & Payment Plan of Care Implemented > F2F must be complete |
2011 Investor Meeting Medicare Billing/Reimbursement Overview 77 PROCESS SUMMARY • Care Team Driven (physician/clinician) • The patient condition, the OASIS, and the Plan-of-Care must match • The patient must agree to the plan |
2011 Investor Meeting Best-in-class processes + systems Leigh Ann Witcher Templeton, VP Office Informatics Kendra Case, VP Clinical Development 78 |
2011 Investor Meeting 79 Leigh Ann Witcher Templeton, VP Office Informatics **LIVE DEMO IN PROGRESS** |
2011 Investor Meeting 80 Point of Care – Clinical Managers Kendra Case, VP Clinical Development |
2011 Investor Meeting MercuryDoc Dave Monic, VP Clinical Informatics 81 |
2011 Investor Meeting Introduction 82 |
2011 Investor Meeting Mercury Doc: Stats Over 8,000 physicians currently enrolled Over 50,000 home health orders processed each month 1/3 of Amedisys patient volume is processed through MercuryDoc |
2011 Investor Meeting Mercury Doc Physician Advantages Less paperwork Greater efficiency = MORE TIME FOR PATIENTS! |
2011 Investor Meeting Mercury Doc Physician Advantages Online access to home care patients’: • Demographic info • Medication, allergy & pharmacy info • Graphed trends & vitals • Wound care info • Refer patients to Amedisys Complementary to the physician |
2011 Investor Meeting Future of Mercury Doc Physician-driven AMDAG: • Amedisys Medical Director Advisory Group • Established in July of 2005 as the Quality and Technology Board • Direct Feedback from Physicians on Emerging Technologies • Aid in Design and Quality Assurance Survey: • Survey done semi-annually • Development is driven by physicians, therefore, participation is vital. • Prompted to participate when logging into product. • Survey takes less than ten (10) minutes to complete. – Seven (7) multiple choice questions. – Three (3) free text questions. |
2011 Investor Meeting Mercury Doc: Future Enhancements • Amedisys is constantly gathering physician input on how to enhance MercuryDoc to remain in step with ever changing physician work flow needs. • We are currently working on 2010 AMDAG recommendations regarding managing/reducing re-hospitalizations What are doctors saying about… |
2011 Investor Meeting 88 Questions & Answers Afternoon Session |
2011 Investor Meeting Compliance @ Amedisys A Comparison of Amedisys Compliance to OIG Best Practices Jeffrey Jeter, Chief Compliance Officer 89 |
2011 Investor Meeting Federal Perspectives on Health Care Fraud Prevention OIG Health Care Fraud Prevention & Enforcement Action Team (HEAT) 90 February-April, 2011: OIG HEAT Provider Compliance Training What are the best practices reflecting a strong culture of compliance? |
2011 Investor Meeting Seven Fundamental Elements of Compliance 91 |
2011 Investor Meeting Compliance Fundamental #1: Written Policies, Procedures, Standards 92 |
2011 Investor Meeting Compliance Fundamental #1: Written Policies, Procedures, Standards 93 • Adopted in 1999 • Consistent with OIG Model Compliance Plan Guidance for both Home Health and Hospice. • Revisions made in 1999, 2000, 2002, 2003, 2006, 2008, 2009, 2010, 2011. • Disseminated company-wide via Amedisys Intranet (Amedisys @ Work). Amedisys Practice |
2011 Investor Meeting Compliance Fundamental #2: Access to Compliance Professionals 94 OIG Best Practice |
2011 Investor Meeting • Designation of Chief Compliance Officer • Designation of Compliance Committee • Access to Board of Directors, Management • Professional Staff OIG Best Practice Compliance Fundamental #2: Access to Compliance Professionals 95 |
2011 Investor Meeting - Jeffrey Jeter, former health care fraud prosecutor - CEO, COO, CFO, CDO, CMO, CIO, CCO, SVP-Internal Audit, SVP-Clinical Informatics, VP-Compliance - Quarterly reports to Board of Directors - Executive Session with independent directors - Direct access to chair of Audit Committee (SOX) - Staff of 21 dedicated employees. - Includes 11 clinical auditors, 2 attorneys, 1 CPA/CIA • Designation of Chief Compliance Officer • Designation of Compliance Committee • Access to Board of Directors, Management • Professional Staff Amedisys Practice Compliance Fundamental #2: Access to Compliance Professionals 96 |
2011 Investor Meeting Compliance Fundamental #3: Effective Training & Education 97 OIG Best Practice |
2011 Investor Meeting Compliance Fundamental #3: Effective Training & Education 98 • Mandatory general compliance training upon hire • Mandatory refresher training annually • Mandatory HIPAA training annually • Targeted training for billing staff • Targeted training for business development staff Amedisys Practice |
2011 Investor Meeting Compliance Fundamental #4: Effective Communication 99 OIG Best Practice |
2011 Investor Meeting Compliance Fundamental #4: Effective Communication 100 • Toll-Free Compliance Hotline • Toll-Free HIPAA Hotline • Exit Interviews • Monthly Polling • Confidentiality / Non-retaliation policy • Compliance Educational Bulletins Amedisys Practice |
2011 Investor Meeting Compliance Fundamental #5: Internal Monitoring 101 OIG Best Practice |
2011 Investor Meeting • Clinical Audits (Services, Coding, and Care) - Complaint Audits - Compliance Scorecard Audits - Annual Work Plan Audits - Due Diligence Audits • Medical Director Contract & Invoice Review • Expense Report Monitoring • Training & Marketing Material Reviews Amedisys Practice Compliance Fundamental #5: Internal Monitoring 102 |
2011 Investor Meeting Compliance Fundamental #5: Internal Monitoring 103 • Clinical Audits (all-inclusive) • Medical Director Contract Review • Medical Director Payment Review • Expense Report Monitoring • Training & Marketing Material Reviews Amedisys Practice |
2011 Investor Meeting Compliance Fundamental #5: Internal Monitoring 104 OIG Best Practice |
2011 Investor Meeting Compliance Fundamental #5: Internal Monitoring 105 •Compliance Risk Scorecard - Home Health (since 2008) - Hospice (currently under development) •2010 — 282 full scale audits and 750 limited scope chart reviews. •2010—5 company-wide special project audits (tied to OIG Annual Workplan) •Special compliance audits conducted on all acquisition targets. Amedisys Practice |
2011 Investor Meeting 106 Compliance Fundamental #5: Proactive Internal Monitoring Consolidated Compliance Risk 100% Roll-Up Company Average Up to 2 Standard Deviations 2 Standard Deviations Operational Risks Company Average Up to 2 Standard Deviations 2 Standard Deviations Clinical Risks Company Average Up to 2 Standard Deviations 2 Standard Deviations Revenue Risks Company Average Up to 2 Standard Deviations 2 Standard Deviations Complaint Risks Company Average Up to 2 Standard Deviations 2 Standard Deviations Regulatory Risks Company Average Up to 2 Standard Deviations 2 Standard Deviations Environmental Risks Company Average Up to 2 Standard Deviations 2 Standard Deviations |
2011 Investor Meeting HOSPICE COMPLIANCE SCORECARD (Under Development in 2011) Compliance Fundamental #5: Proactive Internal Monitoring |
2011 Investor Meeting Compliance Fundamentals #s 6 & 7: Enforcement of Standards, Prompt Response 108 OIG Best Practice |
2011 Investor Meeting Compliance Fundamentals #s 6 & 7: Enforcement of Standards, Prompt Response 109 Amedisys Practice •Zero Tolerance Policy •Expanded Zero Tolerance •Disciplinary action up to and including termination. •Employees who engage in fraudulent conduct are reported to professional licensing boards. •Corrective action plans and training are required remediation with any audit. |
2011 Investor Meeting Amedisys Compliance vs. OIG Best Practices 110 These best practices reflect a culture of compliance, which means doing the right thing naturally. Lewis Morris, Chief Counsel to the OIG, 04-12-2011 |
2011 Investor Meeting 111 Questions & Answers Compliance |
2011 Investor Meeting 112 Closing Remarks William F. Borne, Chairman and CEO Mike Snow, Chief Operating Officer |
Evolution of traditional home health 113 |
Thank you 2011 Investor Meeting - NYC April 2011 |